A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present case, a non-small cell lung cancer patient with an epidermal growth factor receptor (EGFR)-sensitive mutation was...
Main Authors: | Caibao Jin, Bin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-04-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/514050 |
Similar Items
-
Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report
by: Hiroaki Matsuura, et al.
Published: (2024-06-01) -
Characterizing the secretome of EGFR mutant lung adenocarcinoma
by: Jennifer K. Luu, et al.
Published: (2024-01-01) -
Tuberculosis and lung cancer
by: Camilo Molina-Romero, et al.
Published: (2019-06-01) -
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
by: Woraseth Saifon, et al.
Published: (2022-09-01) -
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
by: Soei Gen, et al.
Published: (2022-06-01)